SG11202113174SA - Medicament and use thereof for treating bacterial infections involving biofilm - Google Patents
Medicament and use thereof for treating bacterial infections involving biofilmInfo
- Publication number
- SG11202113174SA SG11202113174SA SG11202113174SA SG11202113174SA SG11202113174SA SG 11202113174S A SG11202113174S A SG 11202113174SA SG 11202113174S A SG11202113174S A SG 11202113174SA SG 11202113174S A SG11202113174S A SG 11202113174SA SG 11202113174S A SG11202113174S A SG 11202113174SA
- Authority
- SG
- Singapore
- Prior art keywords
- medicament
- bacterial infections
- treating bacterial
- infections involving
- biofilm
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19180281 | 2019-06-14 | ||
PCT/EP2020/066305 WO2020249731A1 (en) | 2019-06-14 | 2020-06-12 | Afabicin for use for treating bacterial infections involving biofilm |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202113174SA true SG11202113174SA (en) | 2021-12-30 |
Family
ID=66867028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202113174SA SG11202113174SA (en) | 2019-06-14 | 2020-06-12 | Medicament and use thereof for treating bacterial infections involving biofilm |
Country Status (15)
Country | Link |
---|---|
US (1) | US20230126947A1 (en) |
EP (1) | EP3982975A1 (en) |
JP (1) | JP7418475B2 (en) |
KR (1) | KR20220020963A (en) |
CN (1) | CN113939306A (en) |
AU (1) | AU2020293635A1 (en) |
BR (1) | BR112021025306A8 (en) |
CA (1) | CA3139942A1 (en) |
CL (1) | CL2021003317A1 (en) |
EA (1) | EA202290048A1 (en) |
IL (1) | IL288861A (en) |
MA (1) | MA56184A (en) |
MX (1) | MX2021015513A (en) |
SG (1) | SG11202113174SA (en) |
WO (1) | WO2020249731A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2610716A1 (en) * | 2005-05-31 | 2006-12-07 | Cubist Pharmaceuticals, Inc. | Daptomycin for the treatment of biofilm and catheter salvage |
SI2861608T1 (en) | 2012-06-19 | 2019-08-30 | Debiopharm International Sa | Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide |
FR3017294B1 (en) | 2014-02-07 | 2021-10-01 | Atlangram | LIPID NANOPARTICLES INCLUDING AN ANTIBIOTIC AND THEIR USES IN THERAPY |
CA3014541A1 (en) * | 2016-02-26 | 2017-08-31 | Debiopharm International S.A. | Medicament for treatment of diabetic foot infections |
-
2020
- 2020-06-12 BR BR112021025306A patent/BR112021025306A8/en unknown
- 2020-06-12 JP JP2021572638A patent/JP7418475B2/en active Active
- 2020-06-12 CA CA3139942A patent/CA3139942A1/en active Pending
- 2020-06-12 EA EA202290048A patent/EA202290048A1/en unknown
- 2020-06-12 US US17/618,882 patent/US20230126947A1/en active Pending
- 2020-06-12 MX MX2021015513A patent/MX2021015513A/en unknown
- 2020-06-12 EP EP20733912.8A patent/EP3982975A1/en active Pending
- 2020-06-12 KR KR1020227001532A patent/KR20220020963A/en active Search and Examination
- 2020-06-12 WO PCT/EP2020/066305 patent/WO2020249731A1/en active Application Filing
- 2020-06-12 SG SG11202113174SA patent/SG11202113174SA/en unknown
- 2020-06-12 CN CN202080042971.6A patent/CN113939306A/en active Pending
- 2020-06-12 AU AU2020293635A patent/AU2020293635A1/en active Pending
- 2020-06-12 MA MA056184A patent/MA56184A/en unknown
-
2021
- 2021-12-09 IL IL288861A patent/IL288861A/en unknown
- 2021-12-13 CL CL2021003317A patent/CL2021003317A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CL2021003317A1 (en) | 2022-09-20 |
AU2020293635A1 (en) | 2022-01-27 |
MA56184A (en) | 2022-04-20 |
JP2022535598A (en) | 2022-08-09 |
JP7418475B2 (en) | 2024-01-19 |
WO2020249731A1 (en) | 2020-12-17 |
CN113939306A (en) | 2022-01-14 |
BR112021025306A8 (en) | 2022-09-20 |
US20230126947A1 (en) | 2023-04-27 |
KR20220020963A (en) | 2022-02-21 |
EP3982975A1 (en) | 2022-04-20 |
EA202290048A1 (en) | 2022-03-10 |
BR112021025306A2 (en) | 2022-02-01 |
MX2021015513A (en) | 2022-04-20 |
CA3139942A1 (en) | 2020-12-17 |
IL288861A (en) | 2022-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2587521B (en) | Treating & preventing microbial infections | |
IL271863B (en) | Compounds and use thereof for the treatment of microbial infections | |
IL270976A (en) | Il-8 inhibitors for use in the treatment and/or prevention of bacterial secondary infections | |
EP3768889A4 (en) | Durable antimicrobial treatment of textile for use in healthcare environment | |
ZA202002069B (en) | Novel mek-inhibitor for the treatment of viral and bacterial infections | |
ZA201901963B (en) | Heterocyclic compounds and their use in preventing or treating bacterial infections | |
EP4076420A4 (en) | Compounds for the treatment of bacterial infections and potentiation of antibiotics | |
IL281770A (en) | Indane derivatives for use in the treatment of bacterial infection | |
PL3476397T3 (en) | Novel composition their use in treating bacterial infections | |
DK3630111T3 (en) | Compounds and methods for treating bacterial infections | |
IL278895A (en) | Diltiazem for use in the treatment of microbial infections | |
IL281775A (en) | Methods of treatment of infections using bacteria | |
IL288861A (en) | Medicament and use thereof for treating bacterial infections involving biofilm | |
EP3856747C0 (en) | Substituted pyridoindoles for the treatment and prophylaxis of bacterial infection | |
ZA201904998B (en) | Novel heterocyclic compounds and their use in preventing or treating bacterial infections | |
EP3877012A4 (en) | Methods and composition for treating microbial infections | |
EP3634471A4 (en) | Carbapenem compounds and compositions for the treatment of bacterial infections | |
IL253418A0 (en) | Nisin-based compounds and use thereof in the treatment of bacterial infections | |
GB201806976D0 (en) | Treating and preventing microbial infections | |
EP3766967A4 (en) | Novel bacteriophage and treatment agent for bacterial endophthalmitis | |
GB202210704D0 (en) | Biofilm prevention and treatment | |
EP3876909A4 (en) | Nanodiscs for preventing and treating pathogen infections and methods of use thereof | |
GB201804781D0 (en) | Treating & preventing preventing microbial infections |